Literature DB >> 7873317

Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

B J Maron1, F Cecchi, W J McKenna.   

Abstract

Entities:  

Mesh:

Year:  1994        PMID: 7873317      PMCID: PMC1025670          DOI: 10.1136/hrt.72.6_suppl.s13

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  67 in total

1.  Hypertrophic cardiomyopathy and sudden death.

Authors:  P Nicod; R Polikar; K L Peterson
Journal:  N Engl J Med       Date:  1988-05-12       Impact factor: 91.245

2.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.

Authors:  W J McKenna; R C Franklin; P Nihoyannopoulos; K C Robinson; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1988-01       Impact factor: 24.094

3.  Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy.

Authors:  P Spirito; R M Watson; B J Maron
Journal:  Am J Cardiol       Date:  1987-11-15       Impact factor: 2.778

4.  Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy.

Authors:  A Geibel; P Brugada; M Zehender; W Stevenson; B Waldecker; H J Wellens
Journal:  Am J Cardiol       Date:  1987-09-15       Impact factor: 2.778

5.  Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy.

Authors:  P Spirito; B J Maron; R O Bonow; S E Epstein
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

6.  Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass.

Authors:  B J Maron; A H Kragel; W C Roberts
Journal:  Br Heart J       Date:  1990-05

7.  Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.

Authors:  W J McKenna; J T Stewart; P Nihoyannopoulos; F McGinty; M J Davies
Journal:  Br Heart J       Date:  1990-05

8.  Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.

Authors:  R M Watson; J L Schwartz; B J Maron; E Tucker; D R Rosing; M E Josephson
Journal:  J Am Coll Cardiol       Date:  1987-10       Impact factor: 24.094

Review 9.  Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.

Authors:  K H Kuck; K P Kunze; M Schlüter; C A Nienaber; A Costard
Journal:  Eur Heart J       Date:  1988-02       Impact factor: 29.983

Review 10.  Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study.

Authors:  C Seiler; O M Hess; M Schoenbeck; J Turina; R Jenni; M Turina; H P Krayenbuehl
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

View more
  6 in total

1.  A novel de novo mutation of β-cardiac myosin heavy chain gene found in a twelve-year-old boy with hypertrophic cardiomyopathy.

Authors:  Seigo Okada; Yasuo Suzuki; Takuro Arimura; Akinori Kimura; Hiroko Narumi; Shunji Hasegawa
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

2.  A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.

Authors:  J R Skinner; A Manzoor; A M Hayes; H S Joffe; R P Martin
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

Review 3.  Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 4.  Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy.

Authors:  I Olivotto; B J Maron; F Cecchi
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

5.  A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  Y Okajima; Y Tanabe; M Takayanagi; H Aotsuka
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

6.  Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?

Authors:  Hans-Peter Vosberg
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.